Incyte’s US Approval For PD-1 Inhibitor Zynyz In MCC Draws Muted Response

Unlikely To Prove Competitive

 
• By Ayisha Sharma
  
Wooden background with three drawn emoticon images in middle: sad, neutral and happy. Hand reaching out to place neutral emoticon.
The Approval Milestone Was Met With A Neutral Response • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip